INDICATION

HEXASIIL^® is indicated for active immunization of infants, at or above the age of 6 weeks against Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis and invasive diseases caused by Haemophilus influenzae type b for 3 dose regimen (6, 10 & 14 Weeks) for primary vaccination and booster dose at the age of 12-24 months.

ROUTE OF ADMINISTRATION

The HEXASIIL^® liquid vaccine vial/PFS should be shaken before use to homogenize the suspension.
HEXASIIL^® should be administered intramuscularly. The recommended injection sites are generally the antero-lateral aspect of the upper thigh in infants and toddlers. Do not administer by intravascular, intradermal or subcutaneous injection.
A sterile syringe and sterile needle must be used for the injection. Any other injection if co-administered with HEXASIIL^® should be given at a different site.

DOSAGE

Primary vaccination :
For active immunization of infants, it is recommended that 3 doses of 0.5 ml to be administered with an interval of at least four weeks between doses starting at six weeks of age.
In countries, where peri-natal transmission of hepatitis B virus (HBV) is common, the first dose of Hepatitis B should be given as soon as possible after birth. In this case, the HEXASIIL^® can be used to complete the primary series from 6 weeks of age.
Booster vaccination :
A booster dose of DTP, Hib and IPV should be given preferably during the second year of life (≥ 6 months after last primary dose). Booster doses should be given in accordance with the official recommendations. Booster dose may be provided to children having received primary vaccination of HEXASIIL^® or any other DTP containing vaccine and Poliomyelitis Vaccine (OPV and/or IPV).